SWOG-9507, Fenretinide in Treating Patients With Neoplasia of the Mouth

Stopped early · Phase 2

Conditions studied: Head and Neck Cancer

In brief

RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. The use of fenretinide may be an effective way to prevent the development of cancer in patients with neoplasia of the mouth. PURPOSE: Phase II trial to study the effectiveness of fenretinide in preventing cancer in patients who have neoplasia of the mouth.

Key facts

Study ID
NCT00003223
Run by
SWOG Cancer Research Network
People needed
5
Starts
1997-12-01
Expected to finish
2000-03-01
Last updated by the study team
2012-07-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.